secwatch / observer
8-K filed May 16, 2024, 7:59 PM ET ticker BCYC CIK 0001761612
other confidence high sentiment neutral materiality 0.15

Bicycle Therapeutics shareholders approve all 11 proposals at 2024 AGM

BICYCLE THERAPEUTICS PLC

item 5.07

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001104659-24-062503
form_type
8-K
ticker
BCYC
cik
0001761612
company_name
BICYCLE THERAPEUTICS PLC
filed_at
2024-05-16T23:59:59+00:00
discovered_at
2026-05-14T18:03:19.951315+00:00
generated_at
2026-06-01T21:33:22.614116+00:00
sec_items
["5.07"]
event_type
other
sentiment
neutral
materiality_score
0.25
calibrated_materiality_score
0.15
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001104659-24-062503
json_url
https://secwatch.observer/filing/0001104659-24-062503.json
markdown_url
https://secwatch.observer/filing/0001104659-24-062503.md
text_url
https://secwatch.observer/filing/0001104659-24-062503.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/0001104659-24-062503-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1761612/000110465924062503/tm2414682d1_8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

07798c60cdcde08718df86944911e954158040be

BICYCLE THERAPEUTICS PLC shareholders approved To approve the directors' remuneration report for the year ended December 31, 2023. at the 2024-05-16 meeting.

Proposal 8 – To approve the directors’ remuneration report for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,200,790 1,188,057 9,260

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

40bec102583ed2d2289a3e5c0c05d3d1fdfcc922

BICYCLE THERAPEUTICS PLC shareholders approved To adopt the new articles of association in substitution for, and to the exclusion of, the Company's existing articles of association. at the 2024-05-16 meeting.

Proposal 11 – To adopt the new articles of association in substitution for, and to the exclusion of, the Company’s existing articles of association. For Against Vote Withheld/Abstain 37,371,711 15,138 11,258

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

419297d81db825634cb37b3c06270d7f6b083dda

BICYCLE THERAPEUTICS PLC shareholders approved To authorize the Audit Committee of the Company's Board of Directors to determine the Company's U.K. statutory auditors' remuneration for the year ending December 31, 2024. at the 2024-05-16 meeting.

Proposal 6 – To authorize the Audit Committee of the Company’s Board of Directors (the “Board”) to determine the Company’s U.K. statutory auditors’ remuneration for the year ending December 31, 2024. For Against Vote Withheld/Abstain 37,376,455 14,150 7,502

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

558cc14f370e2a956ff95ac90ef9c651c681c1ae

BICYCLE THERAPEUTICS PLC shareholders approved To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's definitive proxy statement. at the 2024-05-16 meeting.

Proposal 3 – To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Company’s definitive proxy statement. For Against Vote Withheld/Abstain 36,186,115 1,202,477 9,515

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

9713dd0068a7cc44dcf2a51866ae6535e1cb5ad7

BICYCLE THERAPEUTICS PLC shareholders approved To authorize the Board to allot equity securities for cash up to a maximum aggregate nominal amount of £1,000,000 pursuant to the authorization in Resolution 9 as if U.K. statutory pre-emption rights did not apply. at the 2024-05-16 meeting.

Proposal 10 – To authorize the Board to allot equity securities for cash up to a maximum aggregate nominal amount of £1,000,000 pursuant to the authorization in Resolution 9 as if U.K. statutory pre-emption rights did not apply. For Against Vote Withheld/Abstain 32,350,797 4,154,715 892,595

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

ad85b1ff154b6fb107385b755751233d10c2cb50

BICYCLE THERAPEUTICS PLC shareholders approved To authorize the Board to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company up to a maximum aggregate nominal amount of £1,000,000. at the 2024-05-16 meeting.

Proposal 9 – To authorize the Board to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company up to a maximum aggregate nominal amount of £1,000,000. For Against Vote Withheld/Abstain 33,241,556 4,146,578 9,973

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

d2747917411399b0549191d9ab03c1cfc2a2a056

BICYCLE THERAPEUTICS PLC shareholders approved To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.S. independent registered public accounting firm for the year ending December 31, 2024. at the 2024-05-16 meeting.

Proposal 4 – To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company’s U.S. independent registered public accounting firm for the year ending December 31, 2024. For Against Vote Withheld/Abstain 37,376,526 14,076 7,505

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

d769b58fb372be62bc9fb99c5e324d251812a4ea

BICYCLE THERAPEUTICS PLC shareholders approved To re-elect as a director Kevin Lee. at the 2024-05-16 meeting.

Proposal 1 – To re-elect as a director Kevin Lee. For Against Vote Withheld/Abstain 36,413,260 977,286 7,561

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

df0eb18b925049511adb3741c0489a75615b13e1

BICYCLE THERAPEUTICS PLC shareholders approved To receive and adopt the Company's U.K. statutory annual accounts and reports for the year ended December 31, 2023. at the 2024-05-16 meeting.

Proposal 7 – To receive and adopt the Company’s U.K. statutory annual accounts and reports for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,494,043 896,166 7,898

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

e7ad26cba3d0c1c5fdc18b7c75b7a5cf6f273f85

BICYCLE THERAPEUTICS PLC shareholders approved To re-elect as a director Jose-Carlos Gutierrez-Ramos. at the 2024-05-16 meeting.

Proposal 2 – To re-elect as a director Jose-Carlos Gutierrez-Ramos. For Against Vote Withheld/Abstain 35,019,069 2,371,385 7,653

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

f96cd3195df0281cd26a4d3b182fb848e2569bfe

BICYCLE THERAPEUTICS PLC shareholders approved To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders. at the 2024-05-16 meeting.

Proposal 5 – To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company’s U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders. For Against Vote Withheld/Abstain 37,376,531 14,071 7,505

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

Comparable filings

APCX

AppTech shareholders elect directors, approve say-on-pay and equity plan at annual meeting

AppTech Payments Corp. June 2, 2026, 8:30 AM ET other Items 5.07

same fact type: shareholder_vote same SEC item: 5.07 same event type: other similar materiality

This filing

Proposal 8 – To approve the directors’ remuneration report for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,200,790 1,188,057 9,260

Comparable filing

The appointment of dbbmckennon, LLC as the Company’s independent registered public accounting firm for fiscal year 2026 was ratified by the shareholders: Votes For Against Abstain Broker Non-Votes 25,837,544 78,756 1,648,545 -

Filing page SEC filing

JHG

Janus Henderson shareholders approve all proposals at 2026 AGM

JANUS HENDERSON GROUP PLC June 2, 2026, 6:07 AM ET other Items 5.07

same fact type: shareholder_vote same SEC item: 5.07 same event type: other similar materiality

This filing

Proposal 8 – To approve the directors’ remuneration report for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,200,790 1,188,057 9,260

Comparable filing

shareholders ratified the reappointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year 2026 and authorized the Directors to determine their remuneration (Proposal 5).

Filing page SEC filing

MERC

Mercer International shareholders elect all director nominees, approve say-on-pay, ratify PwC

MERCER INTERNATIONAL INC. June 1, 2026, 5:26 PM ET other Items 5.07

same fact type: shareholder_vote same SEC item: 5.07 same event type: other similar materiality

This filing

Proposal 8 – To approve the directors’ remuneration report for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,200,790 1,188,057 9,260

Comparable filing

Proposal 3: Ratification of Selection of Independent Registered Public Accounting Firm. The selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal 2026 was ratified, and the voting results are set forth below: For Against Abstentions Broker Non-Votes 51,015,419 175,603 524,952 0

Filing page SEC filing

BMRC

Bank of Marin shareholders elect all 10 directors, approve say-on-pay, ratify auditor

Bank of Marin Bancorp June 1, 2026, 5:11 PM ET other Items 5.07, 8.01

same fact type: shareholder_vote same SEC item: 5.07 same event type: other similar materiality

This filing

Proposal 8 – To approve the directors’ remuneration report for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,200,790 1,188,057 9,260

Comparable filing

To elect ten members of the Board of Directors to serve until the next Annual Meeting of Shareholders or until their successors are duly elected and qualified. Number of Votes For Withheld Non-Vote Nicolas C. Anderson 10,405,859 784,544 1,932,287 Russell A. Colombo 7,509,925 3,680,478 1,932,287 Charles D. Fite 10,810,421 379,982 1,932,287 Cigdem F. Gencer 10,818,514 371,888 1,932,287 James C. Hale 10,912,128 278,274 1,932,287 Kevin R. Kennedy 10,974,404 215,998 1,932,287 Timothy D. Myers 10,691,557 498,846 1,932,287 Joel Sklar, MD 10,985,406 204,997 1,932,287 Brian M. Sobel 10,859,501 330,902 1,932,287 Secil T. Watson 10,256,810 933,593 1,932,287

Filing page SEC filing

XBP

XBP Global Holdings annual meeting elects directors, approves auditor and say-on-pay

XBP Global Holdings, Inc. June 1, 2026, 5:00 PM ET other Items 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07 same event type: other similar materiality

This filing

Proposal 8 – To approve the directors’ remuneration report for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,200,790 1,188,057 9,260

Comparable filing

· Proposal 3 — To consider and vote upon a proposal to approve, on an advisory (non-binding) basis, the compensation of our named executive officers (the “say-on-pay vote”): Votes For Votes Against Votes Abstained Broker Non-Votes 8,208,462 1,323,885 1,011 577,920

Filing page SEC filing

NWN

NWN shareholders elect three directors, approve say-on-pay, ratify PwC

Northwest Natural Holding Co June 1, 2026, 4:21 PM ET other Items 5.07

same fact type: shareholder_vote same SEC item: 5.07 same event type: other similar materiality

This filing

Proposal 8 – To approve the directors’ remuneration report for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,200,790 1,188,057 9,260

Comparable filing

Proposal 3: The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2026 was ratified. FOR 35,733,652 AGAINST 1,056,147 ABSTAIN 112,887 BROKER NON-VOTES N/A

Filing page SEC filing

GTX

Garrett Motion shareholders elect all eight directors and ratify Deloitte as auditor

Garrett Motion Inc. June 1, 2026, 4:16 PM ET other Items 5.07

same fact type: shareholder_vote same SEC item: 5.07 same event type: other similar materiality

This filing

Proposal 8 – To approve the directors’ remuneration report for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,200,790 1,188,057 9,260

Comparable filing

Item 2 - Ratification of the appointment of Deloitte SA as the Company's independent registered public accounting firm for the year ending December 31, 2026.

Filing page SEC filing

CLAR

Clarus shareholders elect all five director nominees, approve say-on-pay and auditor ratification

Clarus Corp June 1, 2026, 4:15 PM ET other Items 5.07

same fact type: shareholder_vote same SEC item: 5.07 same event type: other similar materiality

This filing

Proposal 8 – To approve the directors’ remuneration report for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,200,790 1,188,057 9,260

Comparable filing

Proposal 1 – To elect five directors to serve on the Company’s Board of Directors until the next Annual Meeting of Stockholders and until their successors are duly elected and qualified: Name Votes For Votes Withheld Broker Non-Votes Warren B. Kanders 22,373,079 5,085,245 5,086,329 Nicholas Sokolow 20,395,026 7,063,298 5,086,329 Susan Ottmann 22,314,213 5,144,111 5,086,329 Roger Werner 21,940,144 5,518,180 5,086,329 Mark M. Besca 22,037,878 5,420,446 5,086,329

Filing page SEC filing

Source: SEC EDGAR
accession 0001104659-24-062503
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.